Compară metode
Examinează metodele selectate una lângă alta; rândurile care diferă sunt evidențiate.
| Estimator de potrivire augmentat prin învățare automată× | Potrivirea scorului de propensitate× | |
|---|---|---|
| Domeniu≠ | Inferență cauzală | Statistică pentru cercetare |
| Familie≠ | Regression model | Process / pipeline |
| Anul apariției≠ | 2006–2018 | 1983 |
| Autorul original≠ | Abadie & Imbens (classical matching); Chernozhukov et al. (ML augmentation framework) | Paul Rosenbaum and Donald Rubin |
| Tip≠ | Causal inference / nonparametric matching | Method |
| Sursa seminală≠ | Chernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. The Econometrics Journal, 21(1), C1-C68. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Denumiri alternative≠ | ML-augmented matching, ML matching estimator, high-dimensional matching estimator, data-adaptive matching estimator | PSM, propensity score weighting, covariate balance |
| Înrudite≠ | 5 | 3 |
| Rezumat≠ | The machine learning-augmented matching estimator combines classical nearest-neighbor or propensity-score matching with ML algorithms — such as lasso, random forests, or gradient boosting — to select covariates, estimate propensity scores, and correct for residual bias. The result is a matching-based causal estimator that remains valid under high-dimensional confounding where traditional hand-specified matching fails. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateSet de date ↗ |
|
|